6.1 Neurotransmission

Neurotransmission is the process by which signaling molecules (neurotransmitters) are released by neurons to affect target cells. Understanding neurotransmitter systems is fundamental to CNS pharmacology.

Glutamate - Excitatory Neurotransmission

Glutamate Receptors

Ionotropic: NMDA, AMPA, Kainate receptors (ligand-gated ion channels)

Metabotropic: mGluR1-8 (G-protein coupled receptors)

NMDA Receptor

Requires glycine co-agonist and membrane depolarization to relieve Mg²⁺ block

Permeable to Ca²⁺—critical for synaptic plasticity and learning

Excitotoxicity

Excessive glutamate → Ca²⁺ overload → neuronal death

Occurs in stroke, trauma, neurodegenerative diseases

GABA - Inhibitory Neurotransmission

GABAA Receptor

Cl⁻ ionotropic channel, pentameric structure (α, β, γ subunits)

Target for benzodiazepines, barbiturates, anesthetics, alcohol

GABAB Receptor

Gi/o-coupled GPCR, activates K⁺ channels, inhibits Ca²⁺ channels

Baclofen (muscle relaxant) is selective agonist

GABA Synthesis & Degradation

Synthesis: Glutamate → GABA (via glutamic acid decarboxylase, GAD)

Degradation: GABA → Succinate (via GABA transaminase)

Dopamine

D1-like Receptors (D1, D5)

Gs-coupled → ↑ cAMP

Postsynaptic, excitatory effects

D2-like Receptors (D2, D3, D4)

Gi/o-coupled → ↓ cAMP

Pre- and postsynaptic, inhibitory

Dopaminergic Pathways

Nigrostriatal: Motor control (Parkinson's)

Mesolimbic: Reward, addiction

Mesocortical: Cognition, executive function

Tuberoinfundibular: Prolactin regulation

Metabolism

MAO (monoamine oxidase) → DOPAC

COMT (catechol-O-methyltransferase) → 3-MT

Both → HVA (homovanillic acid)

Serotonin (5-HT)

Serotonin Receptors

14 subtypes (5-HT1–5-HT7), mostly GPCRs

Exception: 5-HT3 is ligand-gated Na⁺/K⁺ channel

Key Subtypes

5-HT1A: Anxiolytic effects (buspirone target)

5-HT2A: Psychedelic effects, antipsychotic target

5-HT3: Antiemetic target (ondansetron)

Synthesis & Reuptake

Tryptophan → 5-HTP → 5-HT (via tryptophan hydroxylase)

SERT (serotonin transporter): SSRI target

Norepinephrine (Noradrenaline)

α-Adrenergic Receptors

α₁: Gq-coupled → vasoconstriction

α₂: Gi-coupled → presynaptic inhibition

β-Adrenergic Receptors

β₁: Heart (↑ HR, contractility)

β₂: Bronchodilation, vasodilation

All Gs-coupled → ↑ cAMP

Locus Coeruleus

Major NE source in CNS

Regulates arousal, attention, stress response

Metabolism

MAO and COMT degrade NE

NET (norepinephrine transporter): reuptake